arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

TELEFLEX INC

TFX
$134.92 ▼ -4.29 (-3.08%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
71 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Bearish
auto_awesome

Analytical Summary

TELEFLEX INC faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.0B
Dividend Yield 0.25%
Revenue Growth -21.8%
Op. Margin 3.7%
ROIC 0.5%
FCF / Share
Trailing P/E
Price / Book 1.9x
FCF Yield
Debt / Equity 0.82
info Valuation on last close. End-of-day price, Aug 7, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$548.26M
↓ -21.8%
Net Income Profit after all expenses
$-8.15M
↑ +98.9%
Operating Margin Operating profit as % of sales
3.7%
↑ +106.0% 46th
Long-Term Debt Long-term obligations
$2.51B
↓ -4.8%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
26
Returns
23
Financial Health
44

Dividend History

Dividend / share · sourced from SEC filings
$1.36 Latest / share
+0.0% YoY
+0.0% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters